Biological Activity of the Carrier as a Factor in Immunogen Design for Haptens

Immunoanalytical methods are frequently employed in the detection of hazardous small molecular weight compounds. However, antibody development for these molecules is a challenge, because they are haptens and cannot induce a humoral immune response in experimental animals. Immunogenic forms of hapten...

Full description

Bibliographic Details
Main Authors: Özlem Ertekin, Esin Akçael, Harun Kocaağa, Selma Öztürk
Format: Article
Language:English
Published: MDPI AG 2018-11-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/23/11/2977
_version_ 1819117525891284992
author Özlem Ertekin
Esin Akçael
Harun Kocaağa
Selma Öztürk
author_facet Özlem Ertekin
Esin Akçael
Harun Kocaağa
Selma Öztürk
author_sort Özlem Ertekin
collection DOAJ
description Immunoanalytical methods are frequently employed in the detection of hazardous small molecular weight compounds. However, antibody development for these molecules is a challenge, because they are haptens and cannot induce a humoral immune response in experimental animals. Immunogenic forms of haptens are usually prepared by conjugating them to a protein carrier which serves as an immune stimulator. However, the carrier is usually considered merely as a bulk mass, and its biological activity is ignored. Here, we induced an endocytic receptor, transferrin receptor, by selecting its ligand as a carrier protein to enhance antibody production. We conjugated aflatoxin, a potent carcinogenic food contaminant, to transferrin and evaluated its potential to stimulate antibody production with respect to ovalbumin conjugates. Transferrin conjugates induced aflatoxin-specific immune responses in the second immunization, while ovalbumin conjugates reached similar antibody titers after 5 injections. Monoclonal antibodies were successfully developed with mice immunized with either of the conjugates.
first_indexed 2024-12-22T05:34:22Z
format Article
id doaj.art-6f7e079d83574c92bec18fba3d41cab3
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-12-22T05:34:22Z
publishDate 2018-11-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-6f7e079d83574c92bec18fba3d41cab32022-12-21T18:37:21ZengMDPI AGMolecules1420-30492018-11-012311297710.3390/molecules23112977molecules23112977Biological Activity of the Carrier as a Factor in Immunogen Design for HaptensÖzlem Ertekin0Esin Akçael1Harun Kocaağa2Selma Öztürk3TÜBİTAK, The Scientific and Technological Research Council of Turkey, Marmara Research Center, Genetic Engineering and Biotechnology Institute, 41470 Gebze, Kocaeli, TurkeyTÜBİTAK, The Scientific and Technological Research Council of Turkey, Marmara Research Center, Genetic Engineering and Biotechnology Institute, 41470 Gebze, Kocaeli, TurkeyTÜBİTAK, The Scientific and Technological Research Council of Turkey, Marmara Research Center, Genetic Engineering and Biotechnology Institute, 41470 Gebze, Kocaeli, TurkeyTÜBİTAK, The Scientific and Technological Research Council of Turkey, Marmara Research Center, Genetic Engineering and Biotechnology Institute, 41470 Gebze, Kocaeli, TurkeyImmunoanalytical methods are frequently employed in the detection of hazardous small molecular weight compounds. However, antibody development for these molecules is a challenge, because they are haptens and cannot induce a humoral immune response in experimental animals. Immunogenic forms of haptens are usually prepared by conjugating them to a protein carrier which serves as an immune stimulator. However, the carrier is usually considered merely as a bulk mass, and its biological activity is ignored. Here, we induced an endocytic receptor, transferrin receptor, by selecting its ligand as a carrier protein to enhance antibody production. We conjugated aflatoxin, a potent carcinogenic food contaminant, to transferrin and evaluated its potential to stimulate antibody production with respect to ovalbumin conjugates. Transferrin conjugates induced aflatoxin-specific immune responses in the second immunization, while ovalbumin conjugates reached similar antibody titers after 5 injections. Monoclonal antibodies were successfully developed with mice immunized with either of the conjugates.https://www.mdpi.com/1420-3049/23/11/2977carrier proteinhapten immunizationtransferrin receptorimmunogenendocytosis
spellingShingle Özlem Ertekin
Esin Akçael
Harun Kocaağa
Selma Öztürk
Biological Activity of the Carrier as a Factor in Immunogen Design for Haptens
Molecules
carrier protein
hapten immunization
transferrin receptor
immunogen
endocytosis
title Biological Activity of the Carrier as a Factor in Immunogen Design for Haptens
title_full Biological Activity of the Carrier as a Factor in Immunogen Design for Haptens
title_fullStr Biological Activity of the Carrier as a Factor in Immunogen Design for Haptens
title_full_unstemmed Biological Activity of the Carrier as a Factor in Immunogen Design for Haptens
title_short Biological Activity of the Carrier as a Factor in Immunogen Design for Haptens
title_sort biological activity of the carrier as a factor in immunogen design for haptens
topic carrier protein
hapten immunization
transferrin receptor
immunogen
endocytosis
url https://www.mdpi.com/1420-3049/23/11/2977
work_keys_str_mv AT ozlemertekin biologicalactivityofthecarrierasafactorinimmunogendesignforhaptens
AT esinakcael biologicalactivityofthecarrierasafactorinimmunogendesignforhaptens
AT harunkocaaga biologicalactivityofthecarrierasafactorinimmunogendesignforhaptens
AT selmaozturk biologicalactivityofthecarrierasafactorinimmunogendesignforhaptens